Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Axogen (AXGN) over the last 15 years, with Q3 2025 value amounting to $1.5 million.

  • Axogen's Capital Expenditures rose 15460.64% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 1864.41%. This contributed to the annual value of $3.1 million for FY2024, which is 7764.56% down from last year.
  • Per Axogen's latest filing, its Capital Expenditures stood at $1.5 million for Q3 2025, which was up 15460.64% from $722000.0 recorded in Q2 2025.
  • Over the past 5 years, Axogen's Capital Expenditures peaked at $9.7 million during Q3 2021, and registered a low of $256000.0 during Q1 2025.
  • Moreover, its 5-year median value for Capital Expenditures was $4.0 million (2022), whereas its average is $3.5 million.
  • As far as peak fluctuations go, Axogen's Capital Expenditures plummeted by 8382.11% in 2024, and later skyrocketed by 15460.64% in 2025.
  • Quarter analysis of 5 years shows Axogen's Capital Expenditures stood at $7.2 million in 2021, then dropped by 7.64% to $6.6 million in 2022, then plummeted by 77.91% to $1.5 million in 2023, then tumbled by 54.2% to $670000.0 in 2024, then surged by 126.87% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $722000.0 for Q2 2025, and $256000.0 during Q1 2025.